enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed Feb 17, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 17, 2026

Accession number

0001738048-26-000020

Filer

enGene Therapeutics Inc. (CIK 1980845)